Cardiovascular complications of COVID-19 risk, pathogenesis and outcomes
Mallick, Umair
Cardiovascular complications of COVID-19 risk, pathogenesis and outcomes Umair Mallick. - Cham, Switzerland Springer 2022. - x, 414 pages ; Illustrations.
Includes bibliographies and index.
The Epidemiology of CoViD19 and Cardiovascular Diseases Epidemiology -- Discussion Virology of CoViD19 Viral Characteristics -- Mechanism of Viral Entry in Cells An Introduction to the Clinical and Diagnostic Features, and CoViD19 Complications Clinical Symptomatology -- Sepsis and Complications of CoViD19 -- Important Diagnostic Features The Pathological Features of CoViD19 Cardiovascular Complications Key Features of Cardiovascular Pathology Treatment Options in CoViDI9 Antiviral Agents in CoViD19 -- Amino Quinolones in CoViD19 -- Immune-Based Therapies in CoViD19 -- Potential Anti-inflammatory Mechanisms -- Anticoagulants -- CoViD19 Vaccines An Introduction to the Pathogenetic Mechanisms of CoViD19 Complications Acute Pulmonary Injury -- Sepsis and Multi-organ Failure -- Renin Angiotensin System -- Endothelin System -- Immune-Inflammation Overview of Cytokines and CoViD19 Cytokines -- Cytokine Storm in CoViD19 -- Cytokines in Cardiovascular and Metabolic Diseases The Renin-Angiotensin System in CoViD19 The Renin Angiotensin System -- The Dynamics of ACE2 Expression in CoViD19 -- ACE2 is a Marker of Severity or a Compensatory Mechanism? Thrombosis in CoViD19 Mechanisms Promoting Thrombosis in CoViD19 Pathogenesis of CoViD19- Miscellaneous Mechanisms Regulatory Peptide Systems in CoViD19 -- Miscellaneous Mechanisms Myocardial Injury in CoViD19 Epidemiology of Myocardial Injury -- Definition, Presentation, and Challenges of Myocardial Injury -- Timing and Assessment of Myocardial Injury -- Biomarkers of Myocardial Injury -- Pathogenesis of the Myocardial Injury Heart Failure in CoViD19 Epidemiology -- Role of Comorbidities in Heart Failure with CoViD19 -- Biomarkers of Heart Failure in CoViD19 -- Pathogenetic Mechanisms of Heart Failure in CoViD19 Hypertension in CoViD19 Epidemiology -- Complexities in Hypertension and CoViD19 -- CoViD19 Susceptibility and Hypertension -- Pathogenesis Cardiac Arrhythmias in CoViD19 Epidemiology of Arrhythmias in CoViD19 -- Pathogenesis of Arrhythmias in CoViD19 Acute Coronary Syndromes in CoViD19 Epidemiology of Acute Coronary Syndromes in CoViD19 -- Defining Acute Coronary Syndromes, Challenges in Presentation and Assessment -- Pathogenesis of Acute Coronary Syndromes in CoViD19 Diabetes Mellitus and COVID19 Epidemiology -- Pathogenesis -- Treatment Implications Obesity and COVID19 Pathogenetic Links - Obesity and CoViD19 The Older Age Adults and CoViD19 -- Epidemiology Gender Disparity in CoViD19 Epidemiology -- Discrepancies in the Epidemiological Data -- Factors Associated with Gender Dichotomy -- Gender Disparity in Immune Response -- Gender Disparity in ACE2 Mechanisms -- Gender Disparity in Cardiovascular Diseases An Overview of Quality of Research in CoViD19 Quality Issues in CoViD19 Research and Improvement Initiatives.
"Cardiovascular Complications of COVID-19: Risk, Pathogenesis and Outcomes provides answers to the increasing numbers of questions related to heart disease in COVID-19, highlighting the association between these pandemics and including risk factors, mechanisms and how these may impact diverse patients populations. It describes how COVID-19 impacts older patients and those with metabolic illnesses such as obesity and diabetes mellitus, while providing an overview of the observed gender dichotomy among patients. It therefore represents an essential resource not only for all cardiovascular physicians but also for any healthcare professionals managing patients with these diseases or those exploring COVID-19."
3030900649 9783030900649
MEDICAL.
RA644 / .C373 2022
Cardiovascular complications of COVID-19 risk, pathogenesis and outcomes Umair Mallick. - Cham, Switzerland Springer 2022. - x, 414 pages ; Illustrations.
Includes bibliographies and index.
The Epidemiology of CoViD19 and Cardiovascular Diseases Epidemiology -- Discussion Virology of CoViD19 Viral Characteristics -- Mechanism of Viral Entry in Cells An Introduction to the Clinical and Diagnostic Features, and CoViD19 Complications Clinical Symptomatology -- Sepsis and Complications of CoViD19 -- Important Diagnostic Features The Pathological Features of CoViD19 Cardiovascular Complications Key Features of Cardiovascular Pathology Treatment Options in CoViDI9 Antiviral Agents in CoViD19 -- Amino Quinolones in CoViD19 -- Immune-Based Therapies in CoViD19 -- Potential Anti-inflammatory Mechanisms -- Anticoagulants -- CoViD19 Vaccines An Introduction to the Pathogenetic Mechanisms of CoViD19 Complications Acute Pulmonary Injury -- Sepsis and Multi-organ Failure -- Renin Angiotensin System -- Endothelin System -- Immune-Inflammation Overview of Cytokines and CoViD19 Cytokines -- Cytokine Storm in CoViD19 -- Cytokines in Cardiovascular and Metabolic Diseases The Renin-Angiotensin System in CoViD19 The Renin Angiotensin System -- The Dynamics of ACE2 Expression in CoViD19 -- ACE2 is a Marker of Severity or a Compensatory Mechanism? Thrombosis in CoViD19 Mechanisms Promoting Thrombosis in CoViD19 Pathogenesis of CoViD19- Miscellaneous Mechanisms Regulatory Peptide Systems in CoViD19 -- Miscellaneous Mechanisms Myocardial Injury in CoViD19 Epidemiology of Myocardial Injury -- Definition, Presentation, and Challenges of Myocardial Injury -- Timing and Assessment of Myocardial Injury -- Biomarkers of Myocardial Injury -- Pathogenesis of the Myocardial Injury Heart Failure in CoViD19 Epidemiology -- Role of Comorbidities in Heart Failure with CoViD19 -- Biomarkers of Heart Failure in CoViD19 -- Pathogenetic Mechanisms of Heart Failure in CoViD19 Hypertension in CoViD19 Epidemiology -- Complexities in Hypertension and CoViD19 -- CoViD19 Susceptibility and Hypertension -- Pathogenesis Cardiac Arrhythmias in CoViD19 Epidemiology of Arrhythmias in CoViD19 -- Pathogenesis of Arrhythmias in CoViD19 Acute Coronary Syndromes in CoViD19 Epidemiology of Acute Coronary Syndromes in CoViD19 -- Defining Acute Coronary Syndromes, Challenges in Presentation and Assessment -- Pathogenesis of Acute Coronary Syndromes in CoViD19 Diabetes Mellitus and COVID19 Epidemiology -- Pathogenesis -- Treatment Implications Obesity and COVID19 Pathogenetic Links - Obesity and CoViD19 The Older Age Adults and CoViD19 -- Epidemiology Gender Disparity in CoViD19 Epidemiology -- Discrepancies in the Epidemiological Data -- Factors Associated with Gender Dichotomy -- Gender Disparity in Immune Response -- Gender Disparity in ACE2 Mechanisms -- Gender Disparity in Cardiovascular Diseases An Overview of Quality of Research in CoViD19 Quality Issues in CoViD19 Research and Improvement Initiatives.
"Cardiovascular Complications of COVID-19: Risk, Pathogenesis and Outcomes provides answers to the increasing numbers of questions related to heart disease in COVID-19, highlighting the association between these pandemics and including risk factors, mechanisms and how these may impact diverse patients populations. It describes how COVID-19 impacts older patients and those with metabolic illnesses such as obesity and diabetes mellitus, while providing an overview of the observed gender dichotomy among patients. It therefore represents an essential resource not only for all cardiovascular physicians but also for any healthcare professionals managing patients with these diseases or those exploring COVID-19."
3030900649 9783030900649
MEDICAL.
RA644 / .C373 2022